Univariate analysis of prognostic factors
Factor . | No. . | Overall survival, % . | P . | Disease-free survival, % . | P . | Relapse-free survival, % . | P . |
---|---|---|---|---|---|---|---|
Timing | .008 | .005 | .378 | ||||
Intensive | 94 | 75 | 67 | 74 | |||
Standard | 52 | 54 | 42 | 66 | |||
Acute GVHD | |||||||
None | 79 | 72 | NA | 58 | NA | 62 | NA |
Grades 1-2 | 58 | 72 | .768* | 65 | .076* | 80 | .006* |
Grades 3-4 | 13 | 15 | < .001* | 15 | .004* | 100 | .84* |
Age, y | .32 | .758 | .05 | ||||
Birth-2 | 19 | 79 | 68 | 68 | |||
3-10 | 68 | 69 | 52 | 62 | |||
11+ | 63 | 61 | 60 | 85 | |||
Chloroma | .699 | .687 | .827 | ||||
Yes | 12 | 67 | 58 | 70 | |||
No | 137 | 67 | 57 | 72 | |||
Liver | .161 | .013 | .01 | ||||
Normal | 95 | 70 | 63 | 78 | |||
Enlarged | 55 | 62 | 48 | 59 | |||
Spleen | .073 | .03 | .011 | ||||
Normal | 95 | 71 | 61 | 78 | |||
Enlarged | 55 | 59 | 49 | 59 | |||
CNS disease | .149 | .941 | .443 | ||||
Yes | 5 | 100 | 60 | 60 | |||
No | 144 | 65 | 57 | 71 | |||
WBC | .311 | .266 | .17 | ||||
Less than 20 × 103/μL | 81 | 72 | 62 | 75 | |||
20-100 × 103/μL | 56 | 61 | 52 | 71 | |||
Greater than 100 × 103/μL | 13 | 66 | 51 | 51 | |||
TDT | .16 | .019 | .342 | ||||
0%-25% | 61 | 67 | 51 | 66 | |||
Greater than 25% | 7 | 50 | 17 | 33 | |||
FAB M5 | .724 | .210 | .027 | ||||
Yes | 20 | 66 | 66 | 95 | |||
No | 129 | 67 | 56 | 67 | |||
Cytogenetics | |||||||
t(15;17) | 6 | 67 | .893 | 67 | .751 | 80 | .773 |
t(8;21) | 17 | 53 | .265 | 47 | .385 | 79 | .831 |
Abnormal 16 | 13 | 77 | .584 | 54 | .505 | 64 | .316 |
Abnormal 11 | 12 | 53 | .375 | 53 | .830 | 83 | .778 |
Factor . | No. . | Overall survival, % . | P . | Disease-free survival, % . | P . | Relapse-free survival, % . | P . |
---|---|---|---|---|---|---|---|
Timing | .008 | .005 | .378 | ||||
Intensive | 94 | 75 | 67 | 74 | |||
Standard | 52 | 54 | 42 | 66 | |||
Acute GVHD | |||||||
None | 79 | 72 | NA | 58 | NA | 62 | NA |
Grades 1-2 | 58 | 72 | .768* | 65 | .076* | 80 | .006* |
Grades 3-4 | 13 | 15 | < .001* | 15 | .004* | 100 | .84* |
Age, y | .32 | .758 | .05 | ||||
Birth-2 | 19 | 79 | 68 | 68 | |||
3-10 | 68 | 69 | 52 | 62 | |||
11+ | 63 | 61 | 60 | 85 | |||
Chloroma | .699 | .687 | .827 | ||||
Yes | 12 | 67 | 58 | 70 | |||
No | 137 | 67 | 57 | 72 | |||
Liver | .161 | .013 | .01 | ||||
Normal | 95 | 70 | 63 | 78 | |||
Enlarged | 55 | 62 | 48 | 59 | |||
Spleen | .073 | .03 | .011 | ||||
Normal | 95 | 71 | 61 | 78 | |||
Enlarged | 55 | 59 | 49 | 59 | |||
CNS disease | .149 | .941 | .443 | ||||
Yes | 5 | 100 | 60 | 60 | |||
No | 144 | 65 | 57 | 71 | |||
WBC | .311 | .266 | .17 | ||||
Less than 20 × 103/μL | 81 | 72 | 62 | 75 | |||
20-100 × 103/μL | 56 | 61 | 52 | 71 | |||
Greater than 100 × 103/μL | 13 | 66 | 51 | 51 | |||
TDT | .16 | .019 | .342 | ||||
0%-25% | 61 | 67 | 51 | 66 | |||
Greater than 25% | 7 | 50 | 17 | 33 | |||
FAB M5 | .724 | .210 | .027 | ||||
Yes | 20 | 66 | 66 | 95 | |||
No | 129 | 67 | 56 | 67 | |||
Cytogenetics | |||||||
t(15;17) | 6 | 67 | .893 | 67 | .751 | 80 | .773 |
t(8;21) | 17 | 53 | .265 | 47 | .385 | 79 | .831 |
Abnormal 16 | 13 | 77 | .584 | 54 | .505 | 64 | .316 |
Abnormal 11 | 12 | 53 | .375 | 53 | .830 | 83 | .778 |
CNS indicates central nervous system; WBC, white blood count; and NA, not applicable.
For comparison to patients who did not develop GVHD.